What do you guys think about Follistem?
August 25, 2015 03:15 PM Eastern Daylight Time
TORRANCE, Calif.–(BUSINESS WIRE)–Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry committed to providing high quality stem cell technologies for regenerative medicine, today announced that they have developed a novel product FolliStem™ for Regrowth of human hair. FolliStem™ is manufactured from Adipose Derived Stem Cells that also contains STEMC8007 the human hair follicle stem cell stimulator. FolliStem™ is applied topically once daily after washing the scalp prior to going to bed. The product has been tested in humans and has produced marked improvements within 40-45 days of application.
FolliStem™ stimulates the growth of hair only if the hair follicle is present or is in a dormant / arrested growth stage. The individuals utilizing this product have noticed positive changes with their hair growth. Images taken before and after the application of FolliStem™ show clear improvement.
FolliStem™ supports human hair follicle proliferation and growth when applied topically once daily to a clean scalp. One of the major benefits of the product is that once treatment is stopped the hair gained remains intact as evidenced by the three month study. The product works equally well for both genders. At present, Celprogen is looking for ideal distributors and is interested in locating bulk manufacturers and distribution chains in both the United States and Internationally.
About Celprogen Inc.
Celprogen Inc. is a global Stem Cell Research & Therapeutics company with a proprietary portfolio of unique products and life science research technologies that include genetic engineering, regenerative medicine, and bio-engineering products for tissue, cosmeceuticals, and organ transplants. Headquartered in Torrance, California, Celprogen is committed to the research, development, and manufacture of high quality Stem Cells, Cancer Stem Cells and Primary Cell Culture products to serve our global community. Additional information about Celprogen is available at http://www.celprogen.com.